Martinengo, Italy

Massimo Arcolin

This inventor holds 1 USPTO granted patent. Top assignee: Nuova Ompi Srl Unipersonale. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Massimo Arcolin: Innovator in Medicament Delivery Systems

Introduction

Massimo Arcolin is a notable inventor based in Martinengo, Italy. He has made significant contributions to the field of medical technology, particularly in the area of drug delivery systems. His innovative approach has led to the development of a unique device designed for the subcutaneous delivery of medicaments.

Latest Patents

Arcolin holds a patent for a "Device for subcutaneous delivery of a medicament." This device features an injection needle and a movement mechanism that allows the needle to transition between a rest position and an injection position. The mechanism includes a pushing member that moves between two service positions and a support member that operates in two positions. Additionally, the device is equipped with compression springs that facilitate the movement of both the pushing and support members, ensuring efficient delivery of medication.

Career Highlights

Massimo Arcolin is currently associated with Nuova Ompi Srl Unipersonale, where he continues to innovate in the medical device sector. His work focuses on enhancing the efficacy and safety of drug delivery methods, which is crucial for patient care.

Collaborations

Arcolin collaborates with talented professionals in his field, including Gaia Giulia Pieri and Christian Riva. These partnerships foster a creative environment that drives innovation and leads to the development of advanced medical technologies.

Conclusion

Massimo Arcolin's contributions to the field of medicament delivery systems exemplify the impact of innovative thinking in healthcare. His patented device represents a significant advancement in how medications can be administered, ultimately improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…